Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
Decision to self-isolate during the COVID-19 pandemic in the UK: a rapid scoping review
Keene CM. et al, (2024), BMJ Open, 14, e084437 - e084437
Relationship Between Tenofovir Diphosphate Concentrations in Dried Blood Spots and Virological Outcomes After Initiating Tenofovir-Lamivudine-Dolutegravir as First-Line or Second-Line Antiretroviral Therapy.
van Heerden JK. et al, (2024), Journal of acquired immune deficiency syndromes (1999), 95, 260 - 267
Supporting re-engagement with HIV services after treatment interruption in South Africa: a mixed method program evaluation of MSF's Welcome Service.
Arendse KD. et al, (2024), Scientific reports, 14
Between empathy and anger: healthcare workers’ perspectives on patient disengagement from antiretroviral treatment in Khayelitsha, South Africa - a qualitative study
Nhemachena T. et al, (2023), BMC Primary Care, 24
Conceptualising engagement with HIV care for people on treatment: the Indicators of HIV Care and AntiRetroviral Engagement (InCARE) Framework
Keene CM. et al, (2023), BMC Health Services Research, 23
Standard-dose versus double-dose dolutegravir in HIV-associated tuberculosis in South Africa (RADIANT-TB): a phase 2, non-comparative, randomised controlled trial.
Griesel R. et al, (2023), The lancet. HIV
Recycling tenofovir in second-line antiretroviral treatment with dolutegravir: outcomes and viral load trajectories to 72 weeks.
Keene CM. et al, (2023), J Acquir Immune Defic Syndr
Initial supplementary dose of dolutegravir in second-line antiretroviral therapy: a non-comparative, double-blind, randomised placebo-controlled trial.
Zhao Y. et al, (2023), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Synthetic auxin herbicides do not injure intermediate wheatgrass or affect grain yield
Shoenberger ED. et al, (2023), Weed Technology
Measuring patient engagement with HIV care in sub‐Saharan Africa: a scoping study
Keene CM. et al, (2022), Journal of the International AIDS Society, 25
Social determinants of health and the double burden of disease in Nepal: a secondary analysis.
Gardner H. et al, (2022), BMC public health, 22
Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line antiretroviral therapy in adults failing a tenofovir-based first-line regimen.
Keene CM. et al, (2021), AIDS (London, England), 35, 1423 - 1432
AntiRetroviral Therapy In Second-line: investigating Tenofovir-lamivudine-dolutegravir (ARTIST): protocol for a randomised controlled trial
Zhao Y. et al, (2021), Wellcome Open Research, 6, 1 - 13
Twenty‐four‐month outcomes from a cluster‐randomized controlled trial of extending antiretroviral therapy refills in ART adherence clubs
Cassidy T. et al, (2020), Journal of the International AIDS Society, 23
How COVID-19 could benefit tuberculosis and HIV services in South Africa.
Keene C. et al, (2020), The Lancet. Respiratory medicine, 8, 844 - 846
‘Only twice a year’: a qualitative exploration of 6-month antiretroviral treatment refills in adherence clubs for people living with HIV in Khayelitsha, South Africa
Keene CM. et al, (2020), BMJ Open, 10, e037545 - e037545
Qualitative interview study exploring frontline managers' contributions to hand hygiene standards and audit: Local knowledge can inform practice.
Gould DJ. et al, (2020), American journal of infection control, 48, 480 - 484
A cluster randomized controlled trial of extending ART refill intervals to six-monthly for anti-retroviral adherence clubs.
Wilkinson L. et al, (2019), BMC infectious diseases, 19